Bone densitometer manufacturer Norland has improved its internationalstatus. The Fort Atkinson, WI, company merged with Stratec Medizintechnik,an x-ray bone densitometer manufacturer based in Birkenfeld, Germany. The two companies have been
Bone densitometer manufacturer Norland has improved its internationalstatus. The Fort Atkinson, WI, company merged with Stratec Medizintechnik,an x-ray bone densitometer manufacturer based in Birkenfeld, Germany.
The two companies have been consolidated under Norland MedicalSystems, a Dutch holding company. Norland Medical Systems hasalso created Osteo Diagnostics to combine the international activitiesof Norland and Stratec.
Norland has pursued an aggressive growth strategy since catheterfirm Cordis sold the company to Novatech Management, an investmentgroup led by Albert S. Waxman, founder and former chairman ofDiasonics (SCAN 5/23/90 and 6/5/91). The chairman and CEO of NorlandMedical Systems is Reynald Bonmati, Waxman's partner in Novatech.
Norland Medical Systems will concentrate research efforts inBirkenfeld and will maintain manufacturing plants in Germany andWisconsin. The company has announced that it will focus on marketingStratec's peripheral quantitative CT system, the XCT-900. TheXCT-900 measures bone density in the wrist and will be marketedto pharmaceutical companies conducting osteoporosis drug research.
The new Norland is still privately owned, but intends to gopublic at some time in the future, according to Bonmati.
BRIEFLY NOTED:
Focusing purely on medical ultrasound, Westmark will take thename of its former subsidiary, Advanced Technology Laboratories,and start trading on the NASDAQ market on June 29 under the symbolATLI. SpaceLabs Medical will also trade on NASDAQ, beginning June17, under the symbol SLMD.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.